Add Yahoo as a preferred source to see more of our stories on Google. Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles in ...
A potential packaging glitch that could compromise sterility has triggered a recall at Sagent Pharmaceuticals. The drugmaker issued a voluntary recall of three lots of injectable phenylephrine ...
A drug used to bring a person’s blood pressure back up after anesthesia is being recalled because it may not be sterile. Sagent Pharmaceuticals announced its nationwide recall of three lots of ...
LYON, FRANCE--(Marketwired - Jun 30, 2014) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) ...
Little dark things shouldn’t be in vials of a drug, which is why one lot of an injection drug used to deal with low blood pressure under anesthesia got recalled. Provepharm said it pulled lot No.
One lot of Phenylephrine hydrochloride Injection, USP, 10 mg/mL is being recalled due to particulate matter found in a vial. Provepharm announced on Jan. 24, 2025 that it has voluntarily recalled one ...
A non-integral crimped vial overseal may result in a non-sterile product. Sagent Pharmaceuticals is recalling 3 lots of Phenylephrine Hydrochloride Injection, USP (10mg/mL) due to potentially loose ...
January 24, 2025 – Collegeville, Pennsylvania – Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Phenylephrine Hydrochloride Injection, USP. Fresenius Kabi Phenylephrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results